American Renal Associates (ARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,164 | 58,136 | 55,965 | 29,293 | 12,902 |
| Depreciation Amortization | 10,120 | 39,665 | 29,428 | 19,521 | 9,604 |
| Income taxes - deferred | -569 | 11,299 | 730 | 729 | 673 |
| Accounts receivable | 2,313 | 17,568 | -107 | 3,286 | 3,632 |
| Accounts payable and accrued liabilities | 7,464 | 2,294 | 2,736 | -2,943 | -6,522 |
| Other Working Capital | 1,853 | 10,280 | 2,224 | -9,172 | -11,561 |
| Other Operating Activity | -7,336 | -10,694 | 6,396 | 11,646 | 7,794 |
| Operating Cash Flow | $21,009 | $128,548 | $97,372 | $52,360 | $16,522 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,351 | -33,748 | -23,705 | -14,053 | -6,406 |
| Net Acquisitions | N/A | -1,555 | N/A | N/A | N/A |
| Investing Cash Flow | $-7,351 | $-35,303 | $-23,705 | $-14,053 | $-6,406 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,506 | 317,485 | 302,306 | 279,555 | 4,881 |
| Debt Repayment | -13,060 | -327,331 | -312,800 | -286,525 | -9,689 |
| Common Stock Issued | 336 | 2,380 | 683 | 536 | 30 |
| Common Stock Repurchased | -367 | N/A | N/A | N/A | N/A |
| Dividend Paid | -257 | -8,729 | -8,715 | -8,680 | -271 |
| Other Financing Activity | -18,054 | -106,344 | -88,364 | -49,076 | -21,880 |
| Financing Cash Flow | $-20,896 | $-122,539 | $-106,890 | $-64,190 | $-26,929 |
| Beginning Cash Position | 71,621 | 100,905 | 100,916 | 100,916 | 100,916 |
| End Cash Position | 64,383 | 71,611 | 67,693 | 75,033 | 84,103 |
| Net Cash Flow | $-7,238 | $-29,294 | $-33,223 | $-25,883 | $-16,813 |
| Free Cash Flow | |||||
| Operating Cash Flow | 21,009 | 128,548 | 97,372 | 52,360 | 16,522 |
| Capital Expenditure | -9,851 | -36,073 | -24,780 | -14,053 | -6,406 |
| Free Cash Flow | 11,158 | 92,475 | 72,592 | 38,307 | 10,116 |